1992
DOI: 10.1016/0090-8258(92)90068-t
|View full text |Cite
|
Sign up to set email alerts
|

Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

1995
1995
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 86 publications
(19 citation statements)
references
References 22 publications
0
13
0
Order By: Relevance
“…Radiotherapy with or without chemotherapy has also proven its efficacy in the treatment of vulvar cancer. Collated literature data show a somewhat lower local control rate of 40% after chemoradiotherapy compared with surgery [128][129][130][131][132][133][134] (Table 5). Radiotherapy in moderate doses combined with chemotherapy, followed by organ sparing surgery has shown its efficacy in preventing stoma formation [135].…”
Section: Radio (Chemo)therapy For Locally Advanced Vulvar Cancermentioning
confidence: 91%
“…Radiotherapy with or without chemotherapy has also proven its efficacy in the treatment of vulvar cancer. Collated literature data show a somewhat lower local control rate of 40% after chemoradiotherapy compared with surgery [128][129][130][131][132][133][134] (Table 5). Radiotherapy in moderate doses combined with chemotherapy, followed by organ sparing surgery has shown its efficacy in preventing stoma formation [135].…”
Section: Radio (Chemo)therapy For Locally Advanced Vulvar Cancermentioning
confidence: 91%
“…Whereas the association of BLEO and irradiation was disappointing [109,110], the use of radiotherapy combined with single-agent 5-FU or 5-FU + MMC [111][112][113][114][115][116][117][118] (Tables 3 and 4) or with 5-FU + CDDP [72,100,[119][120][121][122][123][124][125][126] (Tables 5 and 6) has given promising results. Chemotherapy started at the first day of irradiation and was usually repeated after 4 weeks.…”
Section: Postoperative Adjuvant Treatment Of High-risk Patientsmentioning
confidence: 96%
“…With combined CDDP, 5-FU, and irradiation, Russell et al [120] achieved a clinical complete response in 16 (88.9%) out of 18 patients with locally advanced disease and in 4 (51.7%) out of the 7 patients with recurrent disease. Three (15%) out of the 20 complete responders relapsed within the irradiated areas at 11, 38, and 48 months, respectively.…”
Section: Postoperative Adjuvant Treatment Of High-risk Patientsmentioning
confidence: 96%
“…The median hospital stay for patients undergoing surgery was 18 days (IQR, [15][16][17][18][19][20][21][22][23][24]. Postoperative follow-up revealed necrosis in 3 (14.3%) cases, breakdown of groin wounds in 3 (14.3%), breakdown of vulvar wounds in 7 (31.8%), lymphocele in 14 (63.6%) and chronic lymphedema in 14 (63.6%).…”
Section: Tumor Classification Initial Clinical Tumor (T) and Nodal (N)mentioning
confidence: 99%
“…A number of retrospective analyses have established the feasibility of this new therapeutic approach, and suggested a therapeutic benefit of induction chemoradiation therapy for the treatment of vulvar neoplasms (2,(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). The majority of studies involved patients with locally advanced vulvar neoplasms, but certain studies also included recurrent tumor cases that were not eligible for surgical resection by radical vulvectomy.…”
Section: Introductionmentioning
confidence: 99%